Global Information
회사소개 | 문의 | 비교리스트

중개 재생의료 : 세계 시장 전망(2017-2026년)

Translational Regenerative Medicines - Global Market Outlook (2017-2026)

리서치사 Stratistics Market Research Consulting
발행일 2019년 05월 상품 코드 860177
페이지 정보 영문 158 Pages
가격
US $ 4,150 ₩ 5,009,000 PDF (Single User License)
US $ 5,250 ₩ 6,336,000 PDF (2-5 User License)
US $ 6,350 ₩ 7,664,000 PDF (Site License)
US $ 7,500 ₩ 9,052,000 PDF (Global Site License)


중개 재생의료 : 세계 시장 전망(2017-2026년) Translational Regenerative Medicines - Global Market Outlook (2017-2026)
발행일 : 2019년 05월 페이지 정보 : 영문 158 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

Stratistics MRC에 따르면 세계의 중개 재생의료(Translational Regenerative Medicines) 시장은 2017-2026년간 13.9%의 CAGR로 성장할 전망입니다. 퇴행성 질환(변성질환)의 이환율 증가, 고령 인구의 증가, 선진국에서의 성장 진전 등이 주요 요인입니다.

세계 중개 재생의료 시장의 시장 동향, 경쟁 구도를 분석했으며, 제품 종류·요법·용도 및 지역별 시장 동향, 주요 기업에 대해 조사 및 정리하여 전해드립니다.

목차

제1장 개요

제2장 서론

제3장 시장 동향 분석

  • 서론
  • 성장요인
  • 저해요인
  • 시장 기회
  • 위협
  • 제품 분석
  • 용도 분석
  • 신흥 시장
  • 향후 시장 시나리오

제4장 Porter의 산업 분석

  • 공급업체의 교섭력
  • 바이어의 교섭력
  • 대체품의 위협
  • 신규 진출의 위협
  • 경쟁상 경쟁

제5장 세계의 중개 재생의료 시장 : 제품 종류별

  • 서론
  • 세포
  • 무세포

제6장 세계 중개 재생의료 시장 : 요법별

  • 서론
  • 유전자 치료
  • 세포치료
  • 면역치료
  • 조직공학

제7장 세계의 중개 재생의료 시장 : 용도별

  • 서론
  • 피부과
  • 심혈관
  • 종양학
  • 당뇨병
  • 정형외과
  • 신경학
  • 기타 용도

제8장 세계의 중개 재생의료 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인
    • 기타
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 뉴질랜드
    • 한국
    • 기타
  • 남미
    • 아르헨티나
    • 브라질
    • 칠레
    • 기타
  • 중동 & 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 카타르
    • 남아프리카공화국
    • 기타

제9장 시장의 주요 동향

  • 계약, 제휴, 협업 및 합병사업
  • 인수합병
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제10장 기업 개요

  • Vericel Corporation
  • Gamida Cell Ltd.
  • Athersys, Inc.
  • Orthofix International N.V
  • Anika Therapeutics
  • Novartis
  • Celgene Corporation
  • Brainstorm Cell Therapeutics Inc.
  • Nuvasive, Inc.
  • Medipost
KSA 19.06.25

List of Tables

  • Table 1 Global Translational Regenerative Medicines Market Outlook, By Region (2016-2026) (US $MN)
  • Table 2 Global Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 3 Global Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 4 Global Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 5 Global Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 6 Global Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 7 Global Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 8 Global Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 9 Global Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 10 Global Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 11 Global Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 12 Global Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 13 Global Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 14 Global Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 15 Global Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 16 Global Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 17 Global Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 18 North America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 19 North America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 20 North America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 21 North America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 22 North America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 23 North America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 24 North America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 25 North America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 26 North America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 27 North America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 28 North America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 29 North America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 30 North America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 31 North America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 32 North America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 33 North America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 34 North America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 35 Europe Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 36 Europe Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 37 Europe Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 38 Europe Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 39 Europe Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 40 Europe Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 41 Europe Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 42 Europe Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 43 Europe Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 44 Europe Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 45 Europe Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 46 Europe Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 47 Europe Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 48 Europe Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 49 Europe Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 50 Europe Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 51 Europe Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 52 Asia Pacific Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 53 Asia Pacific Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 54 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 55 Asia Pacific Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 56 Asia Pacific Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 57 Asia Pacific Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 58 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 59 Asia Pacific Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 60 Asia Pacific Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 61 Asia Pacific Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 62 Asia Pacific Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 63 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 64 Asia Pacific Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 65 Asia Pacific Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 66 Asia Pacific Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 67 Asia Pacific Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 68 Asia Pacific Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 69 South America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 70 South America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 71 South America Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 72 South America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 73 South America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 74 South America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 75 South America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 76 South America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 77 South America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 78 South America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 79 South America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 80 South America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 81 South America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 82 South America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 83 South America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 84 South America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 85 South America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
  • Table 86 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)
  • Table 87 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
  • Table 88 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cellular (2016-2026) (US $MN)
  • Table 89 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)
  • Table 90 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)
  • Table 91 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
  • Table 92 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
  • Table 93 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
  • Table 94 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
  • Table 95 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)
  • Table 96 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
  • Table 97 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
  • Table 98 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)
  • Table 99 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)
  • Table 100 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)
  • Table 101 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)
  • Table 102 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases, rise in aging population and growing advancements in developed countries are the major driving factors. However, ethical concerns related to the use of embryonic stem cells in research & development hinders market growth.

Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of the body's repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases.

By Product Type, the Gene therapy segment is expected to have significant growth during the forecast period. Gene therapy assists the foundation for innovative treatments of innumerable musculoskeletal disorders. By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities in the U.S.

Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc., Orthofix International N.V, Anika Therapeutics, Novartis, Celgene Corporation, Brainstorm Cell Therapeutics Inc., Nuvasive, Inc., and Medipost.

Product Types Covered:

  • Cell-Based Products
  • Tissue Engineered Products
  • Gene Therapy Products

Applications Covered:

  • Dermatology
  • Cardiovascular
  • Oncology
  • Diabetes
  • Orthopedic
  • Neurology
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, , and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Translational Regenerative Medicines Market, By Product Type

  • 5.1 Introduction
  • 5.2 Cellular
  • 5.3 Acellular

6 Global Translational Regenerative Medicines Market, By Therapy

  • 6.1 Introduction
  • 6.2 Gene Therapy
  • 6.3 Cell Therapy
  • 6.4 Immunotherapy
  • 6.5 Tissue Engineering

7 Global Translational Regenerative Medicines Market, By Application

  • 7.1 Introduction
  • 7.2 Dermatology
  • 7.3 Cardiovascular
  • 7.4 Oncology
  • 7.5 Diabetes
  • 7.6 Orthopedic
  • 7.7 Neurology
  • 7.8 Other Applications

8 Global Translational Regenerative Medicines Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Vericel Corporation
  • 10.2 Gamida Cell Ltd.
  • 10.3 Athersys, Inc.
  • 10.4 Orthofix International N.V
  • 10.5 Anika Therapeutics
  • 10.6 Novartis
  • 10.7 Celgene Corporation
  • 10.8 Brainstorm Cell Therapeutics Inc.
  • 10.9 Nuvasive, Inc.
  • 10.10 Medipost
Back to Top
전화 문의
F A Q